128459-27-8

Usage

Structure

Derived from the camphanic acid ring system and the sugar alcohol myo-inositol

Function

Alpha-glucosidase inhibitor

Medical Use

Treatment of type 2 diabetes

Mechanism of Action

Slows down digestion and absorption of carbohydrates in the intestines

Mode of Action

Inhibits enzymes that break down complex sugars into simple sugars

Effect

Delays release of glucose into the bloodstream after a meal

Clinical Impact

Helps control blood glucose levels and prevent rapid spikes in blood sugar levels after eating

Importance

Essential for managing diabetes and reducing the risk of complications associated with the disease

Upstream product

• 128459-28-9 1D-1,4,5,6-O-tetrabenzyl-2,3-O-(D-1',7',7'-trimethyl<2.2.1>bicyclohept-2'-ylidene)-myo-inositol 
• 142534-51-8 C₄₂H₆₀O₉Si₂ 
• 87-89-8 D-myo-inositol 
• 109280-15-1 (1R)-(+)-camphor dimethyl acetal 

Downstream Products

• 136774-02-2 D-2,3-O-(D-1,7,7-trimethyl<2.2.1>bicyclohept-2-ylidene)-myo-inositol 1-dibenzylphosphate 
• 15421-51-9 myo-inositol 1-phosphate 
• 74465-19-3 D-myo-Inositol 1,4-bisphosphate 
• 143358-53-6 D-1-O-benzyl-5,6-O-isopropylidene-2,3-O-(trimethyl<2.2.1>bicyclohept-2-ylidene)-myo-inositol 
• 2068-89-5 D-myo-inositol 1,4,5-triphosphate 
• 138480-22-5 D-6-O-benzyl-2,3-O-(D-1,7,7-trimethyl<2.2.1>bicyclohept-2-ylidene)-myo-inositol 
• 138480-21-4 D-6-O-benzyl-2,3-O-(D-1,7,7-trimethyl<2.2.1>bicyclohept-2-ylidene)-1,4,5-tri-O-trimethyl-acetyl-myo-inositol 
• 138480-23-6 D-6-O-benzyl-2,3-O-(D-1,7,7-trimethyl<2.2.1>bicyclohept-2-ylidene)-1,4,5-tri-O-(2-oxo-5,6-benzo-1,3,2-dioxaphosphep-2-yl)myo-inositol 
• 142631-00-3 1D-2,3,4,5-O-tetrabenzoyl-myo-inositol 
• 142534-47-2 1D-1-O-(tert-butyldiphenylsilyl)-3,4-O-(1,1,3,3-tetraisopropyldisiloxanedi-1,3-yl)-myo-inositol 
• 142534-47-2 1D-1-O-(tert-butyldiphenylsilyl)-4,5-O-(1,1,3,3-tetraisopropyldisiloxanedi-1,3-yl)-myo-inositol 
• 120679-78-9 1D-2,3,6-O-tribenzoyl-myo-inositol 
• 142534-38-1 C₅₀H₆₆O₇Si₂ 
• 142534-38-1 C₅₀H₆₆O₇Si₂ 

Relevant academic research and scientific papers

Efficient and systematic syntheses of enantiomerically pure and regiospecifically protected myo-inositols

Efficient and systematic syntheses of a variety of enantiomerically pure and regiospecifically protected myo-inositols, which can be readily used as precursors for most natural and unnatural derivatives of myo-inositol, have been developed. The key strate

The synthesis of homochiral inositol phosphates from myo-inositol

A new synthetic procedure for efficient conversion of myo-inositol into homochiral inositol phosphates is presented, and is illustrated with total synthesis of myo-inositol 1-phosphate, 2-deoxy-myo-inositol 1-phosphate, myo-inositol 3-phosphate, myo-inosi

Expedient Synthesis of D-myo-Inositol 1,4,5-Trisphosphate and D-myo-Inositol 1,4-Bisphosphate

Readily available selfresolving myo-inositol D-camphor 2,3-monoacetal is converted into the title inositol phosphates by the concise procedures utilizing 1,4,5-selective tris-acylation and 1,4-selective bis-silylation of the starting tetrol in the key ste

Synthesis of the enantiomeric 1,4,5,6-tetra-O-benzyl-myo inositols

The synthesis of the optically pure 1,4,5,6-tetra-O-benzyl-myo-inositols was achieved in four steps via diastereomeric 2,3-spiro-acetals of myo-inositol with l- and d-camphor as the key intermediates. Camphor dimethyl acetal was used for the acetalation r